Appropriateness of the standard mortality/incidence ratio in evaluation of completeness of population-based cancer registry data
Background: The magnitude of differences in mortality incidence (M:I) ratios derived from the national mortality source and those derived from cancer registry (CR) databases may be used to determine associated factors. Methods: All information on cancer incidence cases and mortality cases from Janua...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84864503587&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/43142 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Summary: | Background: The magnitude of differences in mortality incidence (M:I) ratios derived from the national mortality source and those derived from cancer registry (CR) databases may be used to determine associated factors. Methods: All information on cancer incidence cases and mortality cases from January 1, 2003 to December 31, 2007 were retrieved from 5 population-based cancer registries in four regions of Thailand. Two sources of mortality were used: death cases within the cancer registries and mortality statistics obtained from the Ministry of Public Health (MOPH). Plots of percentage M:I ratios from cancer registry databases and from national mortality sources against 1 minus 5 years relative survival (1-5yrRS) were used to visualize the correlation between the two mortality sources. A Poisson regression model was used to determine the influence of cancer sites and registries on the M:I ratio/[1-5yrRS]. Results: There was high variability between the standard M:I ratio derived from national mortality compared with 1-5 year RS. The factors affecting M:I ratios are sources of mortality data and misclassification of topographic site as the cause of death. Conclusions: Use of the M:I ratio is not recommended to evaluate completeness of cancer registry data when the quality of mortality data is poor. |
---|